Uncategorized

BOSTON, June 11, 2018 – PRNewswire— Fresenius Medical Care, the world’s largest provider of dialysis products and services, and Humacyte, Inc., a medical research, discovery and development company, today announced a strategic, global partnership and a $150M USD equity investment. This agreement has the potential to make Humacyte’s investigational human acellular vessel, HUMACYL®, available to …

Fresenius Medical Care and Humacyte announce strategic global partnership supported by a $150M equity investment Read More »

New Funding to Advance Research on Humacyte’s Investigational Human Acellular Vessel (HAV) RESEARCH TRIANGLE PARK, N.C. – Humacyte, an innovator in biotechnology and regenerative medicine, has received approximately $650,000 from the Medical Technology Enterprise Consortium (MTEC). This award will help fund the ongoing development and future commercialization of Humacyte’s bioengineered HAV’s application as a conduit for …

Humacyte Receives Award from the Medical Technology Enterprise Consortium Read More »